MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma

NCT07054307 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Penile Cancer

Interventions

DRUG: MRG003
DRUG: HX008

Sponsor

Jiyan Liu

Collaborators

[object Object]
[object Object]